Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
Steuben Foods v. Shibuya Hoppmann — Aseptic Packaging Patent Appeal | PatSnap
Explore in Eureka
Case ID23-1790
FiledApr 2023
ClosedJan 2025
Patent Litigation

Steuben Foods v. Shibuya Hoppmann: Federal Circuit Splits on Six Aseptic Packaging Patents

Steuben Foods asserted six US patents covering aseptic container-filling and sterilization tunnel technology against Shibuya Hoppmann, Shibuya Kogyo, and HP Hood. The Federal Circuit issued a split decision — affirming, reversing, and vacating portions of the lower ruling — and remanded the case after 640 days of appellate proceedings.

Resolution time
640days
640 days from filing to Federal Circuit disposition — above average for a multi-patent appeal
Patents asserted
6
US6536188, US6481468, US6475435, US6209591, US6702985, and US6945013 — six aseptic packaging and sterilization patents asserted
Outcome
Appeal Dismissed in Part
Affirmed-in-part, reversed-in-part, vacated-in-part — portions remanded to lower tribunal
Cost ruling
Remanded
Case returned to lower tribunal for further proceedings on remaining issues
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

Six-Patent Aseptic Packaging Dispute Yields a Fractured Federal Circuit Ruling

Steuben Foods, Inc., the holder of six US patents directed at aseptic container-filling apparatus, sterilization tunnels, and aseptic packaging methods, brought an infringement action against Shibuya Hoppmann Corporation, its Japanese parent Shibuya Kogyo Co., Ltd., and dairy processor HP Hood, LLC. The asserted patents — US6536188, US6481468, US6475435, US6209591, US6702985, and US6945013 — collectively cover the core technologies enabling sterile, high-speed filling of food and beverage containers without heat-treatment of the final package.

On appeal, Case No. 23-1790 was filed at the Federal Circuit on 25 April 2023 and closed on 24 January 2025. The court issued a compound ruling — affirming certain aspects of the lower decision, reversing others, and vacating a further portion — before remanding the unresolved issues for additional proceedings. The basis of termination notes the appeal was also dismissed in part, indicating that one or more discrete issues did not survive jurisdictional or procedural scrutiny at the appellate level.

A 640-day appellate timeline for a six-patent case with three defendants is consistent with the complexity of multi-patent aseptic packaging litigation, though the fractured outcome suggests the panel found meaningful legal error in at least part of the tribunal below while affirming other findings. The partial vacatur and remand means the litigation remains live on remanded issues, and the public record does not disclose which specific patents or claim constructions were affected by each component of the split verdict.

Case at a glance
Case no.23-1790
CourtCourt of Appeals for the Federal Circuit
JudgeN/A
FiledApril 25, 2023
ClosedJanuary 24, 2025
Duration640 days
OutcomeAppeal Dismissed in Part
Verdict causeInfringement Action
BasisAppeal Dismissed in Part
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Court of Appeals for the Federal Circuit via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Appeal Dismissed in Part in 640 days

640 days from filing to Federal Circuit disposition — above average for a multi-patent appeal

Case timeline: Appeal filed APR 25 2023, MAR–APR — 640 days total Horizontal timeline showing the three key events in Steuben Foods, Inc. v Shibuya Hoppmann Corporation from filing to resolution. Source: PACER, Court of Appeals for the Federal Circuit. APR 25 2023 Appeal filed Pre-trial proceedings JAN 24 2025 Appeal Dismissed in Part 640 DAYS TOTAL
Court ruling

Federal Circuit’s split ruling: what affirmed, reversed, vacated, and remanded means

Legal mechanism

What a split Federal Circuit verdict means in practice

An ‘affirmed-in-part, reversed-in-part, vacated-in-part, and remanded’ ruling means the Federal Circuit found no reversible error on certain issues (affirmed), found legal error requiring a different outcome on others (reversed), and nullified further findings without substituting a new result (vacated). The remand directs the lower tribunal to apply the Federal Circuit’s guidance to the vacated and reversed portions — meaning the dispute is not fully resolved.

Compound appellate disposition
Patent holder outcome

Steuben Foods: partial wins preserved, but litigation continues

The affirmance on certain issues protects Steuben Foods’ victories below on those points, preserving enforceability findings that survived Federal Circuit scrutiny. However, the reversals and vacatur on other issues represent setbacks — some lower-court findings in Steuben’s favour no longer stand. The remand keeps Steuben’s enforcement campaign alive, but the outcome on remanded issues remains uncertain and will require further proceedings.

Partial win — remand pending
Challenger outcome

Defendants secure reversals but face continued exposure on remand

Shibuya Hoppmann, Shibuya Kogyo, and HP Hood achieved partial relief — the reversal of certain findings below eliminates specific adverse determinations, and the partial dismissal of the appeal removes some issues entirely. However, the affirmance locks in adverse findings on other issues, and the vacatur with remand means defendants must continue litigating the returned issues at the lower level, sustaining ongoing legal and commercial uncertainty.

Partial win — remand exposure remains
Commercial implications

Fractured ruling prolongs IP uncertainty for aseptic filling equipment market

A split Federal Circuit decision on six aseptic packaging patents leaves the competitive landscape in an intermediate state. Equipment manufacturers and food-and-beverage processors deploying sterilization tunnels and aseptic filling lines cannot yet treat the litigation as resolved. Affirmed findings represent settled law for those claim scopes; reversed and remanded questions remain live risk factors. Third parties should monitor the remand proceedings before relying on this ruling for FTO or clearance purposes.

Monitor remand proceedings
Legal analysis based on PACER docket records for case 23-1790 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffSteuben Foods, Inc.CompanyAseptic food-packaging technology company — holder of six aseptic filling and sterilization patentsSearch in Eureka ↗
DefendantShibuya Hoppmann CorporationCompanyShibuya Hoppmann Corp., Shibuya Kogyo Co., Ltd. (Japanese parent), and HP Hood, LLC (dairy processor)Search in Eureka ↗
Co-DefendantShibuya Kogyo Co., Ltd.CompanySearch in Eureka ↗
Co-DefendantHP Hood, LLCCompanySearch in Eureka ↗
Plaintiff counselCook AlciatiAttorneyCounsel for Steuben Foods, Inc.Search in Eureka ↗
Plaintiff law firmGardella Grace PALaw FirmRepresenting Steuben Foods, Inc.Search in Eureka ↗
Defendant counselAnna G. PhillipsAttorneyCounsel for Shibuya Hoppmann CorporationSearch in Eureka ↗
Defendant counselByron Leroy PickardAttorneyCounsel for Shibuya Hoppmann CorporationSearch in Eureka ↗
Defendant counselDeirdre M. WellsAttorneyCounsel for Shibuya Hoppmann CorporationSearch in Eureka ↗
Defendant counselJohn Christopher RozendaalAttorneyCounsel for Shibuya Hoppmann CorporationSearch in Eureka ↗
Defendant counselWilliam MillikenAttorneyCounsel for Shibuya Hoppmann CorporationSearch in Eureka ↗
Defendant law firmSterne, Kessler, Goldstein & Fox, PLLCLaw FirmRepresenting Shibuya Hoppmann CorporationSearch in Eureka ↗
Presiding judgeJudge N/AJudgeCourt of Appeals for the Federal CircuitSearch in Eureka ↗
Official verdict

Official order — verbatim text

“AFFIRMED-IN-PART, REVERSED-IN-PART, VACATEDIN-PART, AND REMANDED”
Source: PACER Docket, Case 23-1790, Court of Appeals for the Federal Circuit

The compound verdict — affirmed-in-part, reversed-in-part, vacated-in-part, and remanded — reflects the Federal Circuit reviewing the lower tribunal’s findings under differentiated standards of review: claim construction de novo, factual infringement and validity findings for substantial evidence, and any legal conclusions de novo. The partial dismissal of the appeal suggests at least one discrete issue lacked appellate jurisdiction or was procedurally barred. The remand is not a final resolution; the lower tribunal must apply the Federal Circuit’s guidance, and further appeals remain structurally possible.

PACER case 23-1790 · Public docket record Explore in Eureka ↗
Patent at issue

US6536188 and five further patents — aseptic container filling and sterilization tunnel technology

Publication No.US6536188
Application No.US09/306552
Patent details
ProductAseptic container-filling apparatus and methods for sterile packaging lines
Cited in actionApril 25, 2023

Publication No.US6481468
Application No.US09/781636
Patent details
ProductApparatus and methods for aseptic packaging sterilization tunnels
Cited in actionApril 25, 2023

Publication No.US6475435
Application No.US09/330763
Patent details
ProductAseptic packaging methods and sterilization apparatus
Cited in actionApril 25, 2023

Publication No.US6209591
Application No.US09/376992
Patent details
ProductAseptic packaging apparatus and container filling methods
Cited in actionApril 25, 2023

Publication No.US6702985
Application No.US09/354478
Patent details
ProductAseptic packaging sterilization process apparatus
Cited in actionApril 25, 2023

Publication No.US6945013
Application No.US09/871078
Patent details
ProductAseptic packaging filling and sterilization system methods
Cited in actionApril 25, 2023

The six asserted patents — US6536188, US6481468, US6475435, US6209591, US6702985, and US6945013 — were filed as application numbers in the late 1990s and early 2000s, a period of rapid commercial deployment of aseptic packaging lines in the food and dairy industries. The patents collectively protect apparatus and methods for filling containers under aseptic conditions, maintaining sterilization zones within packaging tunnels, and ensuring microbial integrity throughout the filling process — technologies critical to shelf-stable and refrigerated food production at scale.

Steuben Foods’ portfolio represents foundational infrastructure IP in the aseptic filling equipment market. For competitors and OEMs supplying sterilization tunnel equipment to food and dairy processors, these patents create significant freedom-to-operate risk. The participation of HP Hood — a major dairy processor and end-user — signals that Steuben’s enforcement strategy extends beyond equipment manufacturers to the processors who deploy the technology commercially, raising the stakes for any company in the aseptic beverage or dairy supply chain.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should you run an FTO analysis against Steuben Foods’ aseptic packaging patents?

Any organisation designing, manufacturing, or operating aseptic container-filling equipment, sterilization tunnels, or related packaging machinery should treat this six-patent portfolio as a live enforcement risk. The Federal Circuit’s affirmance of at least part of the lower ruling confirms that certain claim scopes have survived appellate scrutiny. Equipment OEMs, dairy processors, beverage companies, and contract fillers deploying aseptic lines should conduct FTO analysis before commercialising or scaling systems that overlap with the affirmed claim constructions.

PatSnap Eureka’s FTO Search Agent can map your product’s technical features against the six asserted patents, identify claim elements that have been judicially construed through the litigation record, and flag which aspects remain in active dispute on remand. Eureka’s prosecution history analysis and prior art landscaping tools help R&D teams identify design-around opportunities before investing in production-scale aseptic filling infrastructure.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US6536188 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar Federal Circuit patent appeals in aseptic packaging and food processing technology

Cases involving multi-patent aseptic packaging assertions at the Federal Circuit, including sterilization apparatus and container-filling method disputes.

🔍
Access 40+ similar cases in PatSnap Eureka
Steuben Foods, Inc. patent enforcement history, Court of Appeals for the Federal Circuit case history, Steuben Foods, Inc.’s full IP portfolio, and comparable case analysis
Steuben Foods prior suitsAseptic filling IPR historyFed Circuit split verdictsShibuya Kogyo IP disputes
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the aseptic packaging IP landscape

A six-patent Federal Circuit split is rare — it signals genuine complexity in claim scope, validity, or infringement across a multi-patent portfolio.

Multi-patent assertion amplifies both leverage and appellate fragmentation risk

Steuben’s six-patent assertion created broad infringement exposure for defendants but also multiplied the number of discrete legal questions on appeal. The split outcome — affirmed, reversed, vacated, and dismissed in part — is a direct consequence of that breadth. Patentees asserting large portfolios should anticipate compound appellate outcomes that neither side can characterise as a clean win.

HP Hood’s presence as a downstream user defendant raises supply-chain litigation risk

The inclusion of dairy processor HP Hood alongside equipment manufacturers Shibuya Hoppmann and Shibuya Kogyo is consistent with an enforcement strategy targeting the full value chain. End-users of aseptic filling equipment should assess their indemnification agreements with equipment suppliers and conduct FTO analysis before deploying sterilization tunnel technology at scale.

🔒
Full strategic analysis in PatSnap Eureka
Unlock full strategic analysis for the aseptic packaging sector, including remand risk assessment and Federal Circuit claim-scope mapping.
Affirmed claim scopesRemand risk timelineFTO design-around paths
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

Steuben v Shibuya — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Monitor the Steuben Foods remand — protect your aseptic filling IP position

With key issues remanded, the Steuben Foods litigation remains a live enforcement risk for aseptic equipment makers and food processors. PatSnap Eureka enables real-time docket monitoring, claim-scope mapping, and FTO analysis across all six asserted patents.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.